DR Reddys director files initial insider Form 3

DR REDDYS LABORATORIES LTD director Arun Madhavan Kumar filed an initial Form 3, which is a required statement of beneficial ownership for insiders.

Accepted by SEC EDGAR 03/27/2026 - 08:36 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD director Arun Madhavan Kumar filed an initial Form 3, which is a required statement of beneficial ownership for insiders. This filing does not list any transactions or holdings and simply establishes his status as a reporting person for future ownership disclosures.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing by Arun Madhavan Kumar mean for RDY?

The Form 3 shows Arun Madhavan Kumar becoming a reporting insider at DR REDDYS LABORATORIES LTD. It is a baseline ownership declaration required by regulators and does not itself indicate any share purchases, sales, or other transactions affecting existing shareholders.

Did Arun Madhavan Kumar buy or sell DR REDDYS (RDY) shares in this Form 3?

No, this Form 3 does not report any share purchases or sales. It only registers Arun Madhavan Kumar as an insider at DR REDDYS LABORATORIES LTD, enabling future reporting of any transactions or ownership changes under SEC disclosure rules.

Is the Form 3 filing for DR REDDYS LABORATORIES LTD a trading signal?

This Form 3 is not a trading signal. It is an administrative disclosure showing that Arun Madhavan Kumar is now an insider required to report his holdings and future trades in DR REDDYS LABORATORIES LTD shares according to U.S. securities regulations.

How does a Form 3 differ from a Form 4 for DR REDDYS (RDY)?

Form 3 is an initial statement when someone becomes an insider at DR REDDYS LABORATORIES LTD. Form 4 is used later to report specific transactions, such as buying, selling, or receiving stock or derivatives, after that insider status is established.

Does the RDY Form 3 show any derivative or option positions?

No, the provided Form 3 data shows no derivative or option positions for Arun Madhavan Kumar. Both the transactions list and derivative summary are empty, so only his status as an insider is established without detailing any specific securities holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

KUMAR ARUN MADHAVAN

(Last) (First) (Middle)

12881 VISCAINO PLACE

(Street)

LOS ALTOS HILLS CALIFORNIA 94022-2519

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ ARUN MADHAVAN KUMAR	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)